Kelley MJ - Search Results

1

Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9.

Lalwani AK, Goldstein JA, Kelley MJ, Luxford W, Castelein CM, Mhatre AN. Lalwani AK, et al. Among authors: kelley mj. Am J Hum Genet. 2000 Nov;67(5):1121-8. doi: 10.1016/S0002-9297(07)62942-5. Epub 2000 Oct 9. Am J Hum Genet. 2000. PMID: 11023810 Free PMC article.

2

Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.

Kelley MJ, Jawien W, Ortel TL, Korczak JF. Kelley MJ, et al. Nat Genet. 2000 Sep;26(1):106-8. doi: 10.1038/79069. Nat Genet. 2000. PMID: 10973260

3

Autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly) is linked to chromosome 22q12-13.

Kelley MJ, Jawien W, Lin A, Hoffmeister K, Pugh EW, Doheny KF, Korczak JF. Kelley MJ, et al. Hum Genet. 2000 May;106(5):557-64. doi: 10.1007/s004390000294. Hum Genet. 2000. PMID: 10914687

4

Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33.

Kelley MJ, Korczak JF, Sheridan E, Yang X, Goldstein AM, Parry DM. Kelley MJ, et al. Am J Hum Genet. 2001 Aug;69(2):454-60. doi: 10.1086/321982. Epub 2001 Jul 10. Am J Hum Genet. 2001. PMID: 11452362 Free PMC article.

5

Genetics professionals are key to the integration of genetic testing within the practice of frontline clinicians.

Scheuner MT, Sales P, Hoggatt K, Zhang N, Whooley MA, Kelley MJ. Scheuner MT, et al. Among authors: kelley mj. Genet Med. 2023 Jan;25(1):103-114. doi: 10.1016/j.gim.2022.09.012. Epub 2022 Oct 28. Genet Med. 2023. PMID: 36301261 Free article.

6

Comparative analysis of traction forces in normal and glaucomatous trabecular meshwork cells within a 3D, active fluid-structure interaction culture environment.

Karimi A, Aga M, Khan T, D'costa SD, Thaware O, White E, Kelley MJ, Gong H, Acott TS. Karimi A, et al. Among authors: kelley mj. Acta Biomater. 2024 Apr 17:S1742-7061(24)00194-6. doi: 10.1016/j.actbio.2024.04.021. Online ahead of print. Acta Biomater. 2024. PMID: 38641184

7

Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).

Patel JN, Jiang C, Owzar K, Hertz DL, Wang J, Mulkey FA, Kelly WK, Halabi S, Furukawa Y, Lassiter C, Dorsey SG, Friedman PN, Small EJ, Carducci MA, Kelley MJ, Nakamura Y, Kubo M, Ratain MJ, Morris MJ, McLeod HL. Patel JN, et al. Among authors: kelley mj. Pharmacogenomics J. 2024 Mar 4;24(2):6. doi: 10.1038/s41397-024-00328-z. Pharmacogenomics J. 2024. PMID: 38438359 Free PMC article.

8

Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer.

Justice AC, Tate JP, Howland F, Gaziano JM, Kelley MJ, McMahon B, Haiman C, Wadia R, Madduri R, Danciu I, Leppert JT, Leapman MS, Thurtle D, Gnanapragasam VJ. Justice AC, et al. Among authors: kelley mj. Eur Urol Oncol. 2024 Jan 2:S2588-9311(23)00289-4. doi: 10.1016/j.euo.2023.11.023. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38171965

9

Dynamic traction force in trabecular meshwork cells: A 2D culture model for normal and glaucomatous states.

Karimi A, Aga M, Khan T, D'costa SD, Cardenas-Riumallo S, Zelenitz M, Kelley MJ, Acott TS. Karimi A, et al. Among authors: kelley mj. Acta Biomater. 2024 Feb;175:138-156. doi: 10.1016/j.actbio.2023.12.033. Epub 2023 Dec 25. Acta Biomater. 2024. PMID: 38151067

10

Utility of Tumor Mutational Burden as a Biomarker for Response to Immune Checkpoint Inhibition in the VA Population.

Scobie MR, Zhou KI, Ahmed S, Kelley MJ. Scobie MR, et al. Among authors: kelley mj. JCO Precis Oncol. 2023 Sep;7:e2300176. doi: 10.1200/PO.23.00176. JCO Precis Oncol. 2023. PMID: 38039430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page